A detailed history of Two Sigma Securities, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 10,584 shares of RAPT stock, worth $10,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,584
Holding current value
$10,160
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$1.05 - $1.72 $11,113 - $18,204
10,584 New
10,584 $12,000
Q3 2021

Nov 15, 2021

SELL
$29.86 - $39.47 $235,028 - $310,668
-7,871 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$17.99 - $40.02 $141,599 - $314,997
7,871 New
7,871 $250,000

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $28.5M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.